Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

L Karen Tubridy


  • Svp, Chief Development Officer at Akebia Therapeutics Inc. (AKBA), 2020-03-03
  • Chief Development Officer at Eleven Biotherapeutics Inc. (EBIO), 2016-07-12
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AKBA $8.70 3,454 84,679 2020-02-28 Filing
EBIO $2.08 4,372 Officer 32,753 2016-06-27 Filing
EBIO $2.85 4,427 Officer 32,973 2015-12-28 Filing